Task Group Charge

To address the similar, but local challenges, of implementation of strategies to reduce lung cancer risk and lung cancer deaths at the local level.  This Task Group will work closely with other Task Groups to brings tools and best practices to state-base initiatives to advance lung cancer control systematically at the state and local level.


Timothy Mullett, MD, MBA

Task Group Chair 
University of Kentucky

Jessica Olson, PhD, MPH

Task Group Vice Chair 
Medical College of Wisconsin

Task Group Members

Alberta Becenti
Indian Health Service

Katie Bathje, MA
American Cancer Society

Cindy Domingo
Maryland Department of Health

Beth Dickson-Gavney, MS
American Cancer Society

Kelly Durden, MA
American Cancer Society

Matthew Facktor, MD
American College of Surgeons

Kathyrn Garfield, JD
The Center for Health Law and Policy Innovation of Harvard Law School

M. Shayne Gallaway, PhD, MPH
Centers for Disease Control and Prevention

Rebecca Haines, MSM, CPXP
American College of Radiology

Rob Headrick, Jr., MD, MBA
CHI Memorial Hospital Chattanooga

Elizabeth Holtsclaw, MA
American Cancer Society

Hope Krebill, RN, BSN, MSW
Midwest Cancer Alliance at the University of Kansas Medical Center

Caleb Levell
American Cancer Society/National Colorectal Cancer Roundtable

William Mayfield, MD
WellStar Health System (GA)

Anita McGlothin
Go2 Foundation for Lung Cancer

Andrea McKee, MD
Lahey Hospital and Medical Center

Jennifer Redmond Knight, DrPH
University of Kentucky College of Public Health

Jeanne Regnante
Sustainable Healthy Communities, LLC

John Ruckdeschel, MD
University of Mississippi Medical Center Cancer Institute

Carey Thomson, MD, MPH
Mt. Auburn Hospital

Nirmil Veeramachaneni, MD
University of Kansas Medical Center

Opportunities For Intervention/Influence:

  • Address local challenges by working with organizations operating at the local level
  • Support the establishment of state-based roundtables – common challenges, common solutions
  • Create opportunities for communication and sharing best practices
  • Create opportunities to identify enduring and new challenges
  • Collaborate with State Health Departments, HRSA, FQHCs, CDC, ACS field staff, etc.
  • Provide data on at-risk populations, screening, diagnostic and therapeutics for local focus and investment to address inequities